NCT07155707

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 156 (estimated)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 5 Years – 14 Years
• Healthy volunteers: Not accepted

Summary

This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Detailed description

This study aims to examine the impact of tailored telehealth psychotherapy environments on clinical outcomes in the context of pediatric mental health treatment. Researchers will conduct a full-scale RCT with 156 families to assess how Teleo compares to standard video conferencing (e.g., Zoom) on a range of clinical metrics, including cancellation/no-show rates, clinician satisfaction, duration of treatment, need for medication, and symptoms of anxiety and depression.

Conditions

• Anxiety
• Mood Disorders

Interventions

Type	Name	Description
OTHER	Teleo	Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.
OTHER	Standard Videoconferencing	Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.

Timeline

• Start date: 2025-09-15
• Primary completion: 2027-09-15
• Completion: 2027-09-15
• First posted: 2025-09-04
• Last updated: 2025-09-23

Locations

2 sites across 1 country: United States